Detection of Preneoplastic or Inflammatory Conditions in the Gastrointestinal Tract

Fardos Bary^*
*Correspondence: Fardos Bary, Department of Science and Technology, University of Dhaka, Dhaka, Bangladesh, Email:

Introduction

Fluorescence spectroscopy depends on the rule that all tissues display endogenous (auto) fluorescence, when enlightened by light of a particular wavelength. Among these, auto fluorescence imaging (AFI) has been demonstrated to be a promising perceptible method for wide-field endoscopic imaging. Here, suspect sores are imagined because of the way that specific tissues produce light with longer frequencies after excitation by a short frequency light source. In the model of AFI the mucosa was enlightened successively with the blue, green and red spectra of the light causing a green reflectance picture without utilizing fluorescent colors Standard for the discovery of preneoplastic or provocative conditions in the upper and lower gastrointestinal (GI) lot. Be that as it may, there is as yet a high miss rate during WLE even of sores with cutting edge histological elements.

Description

Consequently, previously years mechanical upgrades along with benefits and enhancements being developed of sub-atomic tests and neutralizer designing have prompted the fast extension of sub-atomic imaging as a methodology that incorporates essential science and clinical endoscopy. Sub-atomic imaging is another field in gastroenterology in which fluorescently named tests with high explicitness towards with endoscopic gadgets, accordingly empowering perception of single atoms or receptors. Accordingly, sub-atomic imaging centers around the identification of sub-atomic changes as opposed to on perceptible appearances. Molecular imaging is a new field in gastroenterology in which fluorescently labeled probes with high specificity towards defined molecular targets are subsequently detected and visualized with endoscopic devices, thereby enabling visualization of single molecules or receptors. Therefore, molecular imaging focuses on the detection of molecular changes rather than on macroscopic appearances and offers the possibility to visualize targets that are specific and unique for certain diseases. Endoscopic devices utilized for molecular imaging can be generally divided into two categories: macroscopic and microscopic molecular imaging technologies with macroscopic imaging a wieldfield endoscopic image are acquired and hence, macroscopic imaging is suitable for lesion detection and can be used as a “red-flag” technique [1].

Also, to lessen the strain on remote organizations utilizing the authorized range and work on the network limit, the accentuation is to utilize remote advances (commonly low power and more limited range) which works in the unlicensed range i.e., super wideband, 60-GHz, close field correspondences, television blank area, Wi-Fi, Bluetooth, and so forth. Many of the current wireless communication technologies share key technological similarities, and this is also likely to be the case in future wireless systems. The key technology requirements outlined, which are mostly intended for the RF technologies, are very challenging. The peak rate, which is for the ideal conditions, determine the maximum offered bandwidth, coding and modulation schemes that could be supported by the access technology, whereas low latency requirement points to the use of small cells (nano—and femto-cells) in both indoor and outdoor environments with low transmit time interval [2-4].

Hypothetically, the ideal atomic test ought to display quick restricting energy with high explicitness towards a characterized sub-atomic objective furthermore, a high tissue entrance alongside a short half-life all together to limit foundational openness. Antibodies are among the most commonly used probes for molecular imaging with the advantage of highly specific binding. Further, with advances in antibody engineering and amino acid modification in the Fc fragment, serum half-life and specificity can be modified. On the other hand, antibodies bear the risk of immunogenicity and allergenic properties and, due to their large molecular weight of approximately 150 kDa, have a relatively poor tissue penetration. With mutations oftheir Fc domain, one can either increase or decrease the serum half-life without losing the ability of high binding affinity. All the more as of late a trimodal imaging gadget joining Limited Band Imaging (NBI), superior quality WLE and AFI in a solitary endoscope has likewise been acquainted with the market. Another macroscopic technique which can be used for the detection of premalignant conditions is near infrared (NIR) imaging which uses an optimal near infrared light spectrum (i.e. from 650 nm to 900 nm). It has already been shown in a mouse model of colonic adenomatosis that a multichannel miniaturized NIRendoscope can be useful for in vivo imaging of diverse molecular targets. The patient gradually improved over the next few days. On the fifth day of his hospital stay, he was pain-free, and fen fibrate and omega-3 were introduced after intravenous insulin was stopped. The\ patient was discharged the following day with no sign of pain and a triglyceride level of 6.3 mmol/L[5].

Conclusion

Molecular imaging techniques and particularly the exciting new technology of PET/CT offer a number of practical advantages in the evaluation of soft tissue and bone sarcoma. Further studies are required to determine how best to use these techniques to complement conventional imaging or, in some situations, to replace existing investigative paradigms. Accordingly, sub-atomic imaging centers around the identification of sub-atomic changes as opposed to on perceptible appearances. Molecular imaging is a new field in gastroenterology in which fluorescently labeled probes with high specificity towards defined molecular targets are subsequently detected and visualized with endoscopic devices, thereby enabling visualization of single molecules or receptors. Therefore, molecular imaging focuses on the detection of molecular changes rather than on macroscopic appearances and offers the possibility to visualize targets that are specific and unique for certain diseases.

Acknowledgement

We thank the anonymous reviewers for their constructive criticisms of the manuscript. The support from ROMA (Research Optimization and recovery in the Manufacturing industry), of the Research Council of Norway is highly appreciated by the authors.

Conflict of Interest

The Author declares there is no conflict of interest associated with this manuscript.

References

1. Leja, Marcis, M. Constanza Camargo, Inese Polaka and Sergejs Isajevs, et al. "Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays." Helicobacter 22 (2017): e12393.

Google Scholar, Crossref, Indexed at

2. Hosseini, Mosalreza, Sakineh Amoueian, Armin Attaranzadeh and Mehdi Montazer, et al. "Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran." J Res Med Sci 18 (2013): 225.

Google Scholar, Indexed at

3. Terasawa, Teruhiko, Hiroshi Nishida, Katsuaki Katon and Isao Miyashiro, et al. "Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: A systematic review and meta-analysis." PloS one 9 (2014): e109783.

Google Scholar, Crossref, Indexed at

4. Stolte, Manfred and Alexander Meining. "The updated Sydney system: Classification and grading of gastritis as the basis of diagnosis and treatment." Can J Gastroenterol 15 (2001): 591-598.

Google Scholar, Crossref, Indexed at

5. Kim, Eun Hye, Huapyong Kang, Chan Hyuk Park and Hee Seung Choi, et al. "The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis." Dig Liver Dis 47 (2015): 663-668.

Google Scholar, Crossref, Indexed at